Filing Details

Accession Number:
0001209191-20-020799
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-23 21:45:31
Reporting Period:
2020-03-19
Accepted Time:
2020-03-23 21:45:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753281 Ian Taylor C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-19 2,686 $0.00 71,224 No 4 M Direct
Common Stock Disposition 2020-03-19 826 $37.61 70,398 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2020-03-19 2,686 $0.00 2,686 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,056 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
  2. This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
  3. The broker sold shares of Arvinas Common Stock for certain Arvinas employees following the vesting of previously granted Restricted Stock Units, including the Common Stock reported on this Form 4 by the Reporting Person, at an average price of $37.61.
  4. On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.